--Gordon Gekko (Wall Street)
The upside earning beats by Pfizer (PFE), Merck (MRK), and nearly all big pharma this week appeared to be classic sell-the-news events. Nearly all have given back a coupla percent since their announcements.
After the runup many of these names have had, Hoofy will argue that this is healthy action.
Did ditch a small position in Eli Lilly (LLY) and a little PFE, but I'm sticking w/ the Hoofster for awhile.
positions in MRK, PFE
No comments:
Post a Comment